Budesonide (EENT)

Class: Corticosteroids
ATC Class: R01AD05
VA Class: NT200
Chemical Name: [11β,16α(R)]-16,17-Butylidene-bis(oxy)-11,21-dihydroxy-pregna-1,4-diene-3,20-dione and 16α,17-[(S)-butylidinebis(oxy)]-11β,21-dihydroxypregna-1,4-diene-3,20-dione
Molecular Formula: C₂₅H₃₄O₆
CAS Number: 51333-22-3
Brands: Rhinocort Aqua

Medically reviewed by Drugs.com on Oct 20, 2021. Written by ASHP.

Introduction

Synthetic, non-halogenated corticosteroid.

Uses for Budesonide (EENT)

Allergic Rhinitis

Symptomatic treatment of seasonal or perennial allergic rhinitis.

Budesonide (EENT) Dosage and Administration

General

• For therapeutic effectiveness, use at regular intervals.

Administration

Intranasal Inhalation

Administer by nasal inhalation using a metered-dose pump spray.

Shake inhaler gently immediately prior to use.

Prior to initial use, the metered-dose pump spray must be primed with 8 actuations.

If spray pump is not used for 2 consecutive days, partially prime (1 actuation or until a fine spray is observed). If the spray pump is not used for more than 14 days, rinse the applicator and reprime with 2 sprays or until a fine spray appears. Rinse the applicator when not used for more than 14 days.

Clear nasal passages prior to administration.

Tilt the head slightly forward, insert the spray tip into one nostril, and point the tip toward the back of the nose. Pump the drug into one nostril while holding the other nostril closed and concurrently inspire through the nose. Repeat this procedure for the other nostril.

Dosage

After priming, nasal spray pump delivers about 32 mcg of budesonide per metered spray and about 120 metered doses per 8.6-g container.

Pediatric Patients

Titrate dosage to the lowest possible effective level. (See Pediatric Use under Cautions.)

Seasonal Allergic Rhinitis

Intranasal Inhalation

C...